+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Central Venous Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • PDF Icon

    Report

  • 72 Pages
  • June 2023
  • Region: Global
  • GlobalData
  • ID: 5714531
The Medical Devices sector report, “Central Venous Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Central Venous Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A central venous catheter is a long, thin, flexible tube used to administer medicines, fluids, nutrients, or blood products and to monitor haemodynamic status of the patients in surgical and critical care settings over a long period of time, usually several weeks or more.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Central Venous Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Central Venous Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Central Venous Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Central Venous Catheters Overview
3 Products under Development
3.1 Central Venous Catheters - Pipeline Products by Stage of Development
3.2 Central Venous Catheters - Pipeline Products by Segment
3.3 Central Venous Catheters - Pipeline Products by Territory
3.4 Central Venous Catheters - Pipeline Products by Regulatory Path
3.5 Central Venous Catheters - Pipeline Products by Estimated Approval Date
4 Central Venous Catheters - Pipeline Products under Development by Companies
4.1 Central Venous Catheters Companies - Pipeline Products by Stage of Development
4.2 Central Venous Catheters - Pipeline Products by Stage of Development
5 Central Venous Catheters Companies and Product Overview
5.1 Acatechol Inc Company Overview
5.1.1 Acatechol Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Air Force Research Laboratory Company Overview
5.2.1 Air Force Research Laboratory Pipeline Products & Ongoing Clinical Trials Overview
5.3 AngioDynamics Inc Company Overview
5.3.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Ash Access Technology Inc Company Overview
5.4.1 Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Bactiguard Holding AB Company Overview
5.5.1 Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview
5.6 Charite University Hospital of Berlin Company Overview
5.6.1 Charite University Hospital of Berlin Pipeline Products & Ongoing Clinical Trials Overview
5.7 CR Bard Inc Company Overview
5.7.1 CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 DAK Scientific Inc Company Overview
5.8.1 DAK Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 FreeFlow Medical Devices LLC Company Overview
5.9.1 FreeFlow Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview
5.10 Globe Medical Tech Inc (Inactive) Company Overview
5.10.1 Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.11 Lipocoat BV Company Overview
5.11.1 Lipocoat BV Pipeline Products & Ongoing Clinical Trials Overview
5.12 LiquiGlide Inc Company Overview
5.12.1 LiquiGlide Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 Marvao Medical Devices Ltd Company Overview
5.13.1 Marvao Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.14 NHC LLC Company Overview
5.14.1 NHC LLC Pipeline Products & Ongoing Clinical Trials Overview
5.15 Protectus Medical Devices, Inc. Company Overview
5.15.1 Protectus Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.16 S3V Vascular Technologies Company Overview
5.16.1 S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview
5.17 Sharklet Technologies Inc Company Overview
5.17.1 Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 Silver Bullet Therapeutics, Inc. Company Overview
5.18.1 Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.19 Tel Aviv University Company Overview
5.19.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
5.20 Terumo Corp Company Overview
5.20.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
5.21 University of Illinois at Chicago Company Overview
5.21.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
5.22 University of Texas Health Science Center at Houston Company Overview
5.22.1 University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview
5.23 University of Washington Company Overview
5.23.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview
5.24 Velano Vascular East Company Overview
5.24.1 Velano Vascular East Pipeline Products & Ongoing Clinical Trials Overview
5.25 Vindica Therapeutics, Inc Company Overview
5.25.1 Vindica Therapeutics, Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Central Venous Catheters- Recent Developments
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer
List of Tables
  • Central Venous Catheters - Pipeline Products by Stage of Development
  • Central Venous Catheters - Pipeline Products by Segment
  • Central Venous Catheters - Pipeline Products by Territory
  • Central Venous Catheters - Pipeline Products by Regulatory Path
  • Central Venous Catheters - Pipeline Products by Estimated Approval Date
  • Central Venous Catheters Companies - Pipeline Products by Stage of Development
  • Central Venous Catheters - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Central Venous Catheters - Pipeline Products by Stage of Development
  • Central Venous Catheters - Pipeline Products by Segment
  • Central Venous Catheters - Pipeline Products by Territory
  • Central Venous Catheters - Pipeline Products by Regulatory Path
  • Central Venous Catheters - Pipeline Products by Estimated Approval Date

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Acatechol Inc
  • Air Force Research Laboratory
  • AngioDynamics Inc
  • Ash Access Technology Inc
  • Bactiguard Holding AB
  • Charite University Hospital of Berlin
  • CR Bard Inc
  • DAK Scientific Inc
  • FreeFlow Medical Devices LLC
  • Globe Medical Tech Inc (Inactive)
  • Lipocoat BV
  • LiquiGlide Inc
  • Marvao Medical Devices Ltd
  • NHC LLC
  • Protectus Medical Devices, Inc.
  • S3V Vascular Technologies
  • Sharklet Technologies Inc
  • Silver Bullet Therapeutics, Inc.
  • Tel Aviv University
  • Terumo Corp
  • University of Illinois at Chicago
  • University of Texas Health Science Center at Houston
  • University of Washington
  • Velano Vascular East
  • Vindica Therapeutics, Inc